Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Racism | 4 | 2025 | 91 | 1.770 |
Why?
|
| Cognitive Dysfunction | 5 | 2020 | 348 | 1.350 |
Why?
|
| Cardiovascular Diseases | 5 | 2026 | 861 | 1.230 |
Why?
|
| Health Behavior | 3 | 2025 | 482 | 1.190 |
Why?
|
| Atherosclerosis | 2 | 2025 | 159 | 0.980 |
Why?
|
| Allostasis | 3 | 2021 | 10 | 0.910 |
Why?
|
| Aging | 7 | 2024 | 761 | 0.900 |
Why?
|
| Stress, Psychological | 3 | 2021 | 472 | 0.850 |
Why?
|
| Coronary Vessels | 2 | 2022 | 123 | 0.800 |
Why?
|
| Depression | 2 | 2022 | 889 | 0.750 |
Why?
|
| Cognition | 3 | 2025 | 502 | 0.740 |
Why?
|
| Dementia | 4 | 2023 | 272 | 0.710 |
Why?
|
| Minority Groups | 2 | 2019 | 141 | 0.690 |
Why?
|
| Social Determinants of Health | 3 | 2026 | 149 | 0.570 |
Why?
|
| Blood Pressure | 1 | 2019 | 525 | 0.490 |
Why?
|
| Diet | 1 | 2019 | 534 | 0.450 |
Why?
|
| United States | 11 | 2025 | 8050 | 0.410 |
Why?
|
| Risk Factors | 9 | 2026 | 5399 | 0.400 |
Why?
|
| Humans | 35 | 2026 | 64770 | 0.400 |
Why?
|
| Leishmania infantum | 2 | 2023 | 8 | 0.390 |
Why?
|
| Leishmaniasis, Visceral | 2 | 2023 | 14 | 0.390 |
Why?
|
| Coinfection | 2 | 2023 | 58 | 0.370 |
Why?
|
| Male | 22 | 2026 | 30809 | 0.360 |
Why?
|
| Anxiety | 1 | 2015 | 422 | 0.360 |
Why?
|
| Female | 23 | 2026 | 33762 | 0.350 |
Why?
|
| Exercise | 1 | 2019 | 959 | 0.350 |
Why?
|
| DNA Methylation | 2 | 2024 | 301 | 0.340 |
Why?
|
| Aged, 80 and over | 8 | 2026 | 5565 | 0.340 |
Why?
|
| Middle Aged | 11 | 2026 | 18115 | 0.320 |
Why?
|
| Biomarkers | 3 | 2024 | 1467 | 0.320 |
Why?
|
| Feeding and Eating Disorders | 2 | 2022 | 50 | 0.310 |
Why?
|
| Aged | 14 | 2026 | 14843 | 0.300 |
Why?
|
| Young Adult | 5 | 2025 | 4773 | 0.250 |
Why?
|
| Narration | 1 | 2025 | 53 | 0.220 |
Why?
|
| Coronary Artery Disease | 2 | 2026 | 322 | 0.210 |
Why?
|
| Cohort Studies | 4 | 2024 | 2603 | 0.210 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 43 | 0.210 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 405 | 0.200 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 50 | 0.200 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2023 | 16 | 0.200 |
Why?
|
| Parasites | 1 | 2022 | 15 | 0.190 |
Why?
|
| Health Status Disparities | 1 | 2024 | 147 | 0.190 |
Why?
|
| Bulimia | 1 | 2022 | 17 | 0.180 |
Why?
|
| Alzheimer Disease | 3 | 2014 | 759 | 0.180 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 797 | 0.170 |
Why?
|
| Health Promotion | 1 | 2025 | 512 | 0.170 |
Why?
|
| Life Style | 2 | 2022 | 320 | 0.160 |
Why?
|
| Neuropsychological Tests | 4 | 2015 | 409 | 0.160 |
Why?
|
| Social Segregation | 1 | 2020 | 10 | 0.160 |
Why?
|
| Nursing Homes | 3 | 2020 | 674 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2024 | 740 | 0.160 |
Why?
|
| Cancer Pain | 1 | 2020 | 17 | 0.160 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 74 | 0.160 |
Why?
|
| Life Expectancy | 1 | 2019 | 33 | 0.150 |
Why?
|
| Pain Management | 1 | 2020 | 170 | 0.140 |
Why?
|
| Disease Progression | 4 | 2015 | 1210 | 0.140 |
Why?
|
| Pain | 1 | 2020 | 398 | 0.130 |
Why?
|
| Brain | 1 | 2026 | 1594 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 382 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 414 | 0.130 |
Why?
|
| Students | 1 | 2019 | 226 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 734 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 322 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2020 | 524 | 0.120 |
Why?
|
| HIV Infections | 1 | 2022 | 951 | 0.120 |
Why?
|
| Maryland | 1 | 2015 | 36 | 0.110 |
Why?
|
| Irritable Mood | 1 | 2015 | 16 | 0.110 |
Why?
|
| Psychomotor Agitation | 1 | 2015 | 20 | 0.110 |
Why?
|
| Apathy | 1 | 2015 | 9 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 406 | 0.110 |
Why?
|
| Hypertension | 1 | 2020 | 609 | 0.110 |
Why?
|
| Binge-Eating Disorder | 1 | 2014 | 13 | 0.110 |
Why?
|
| Adult | 7 | 2026 | 17239 | 0.110 |
Why?
|
| Smoking | 1 | 2019 | 860 | 0.100 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 1274 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 160 | 0.100 |
Why?
|
| Brazil | 2 | 2023 | 102 | 0.100 |
Why?
|
| Quality of Life | 1 | 2020 | 1254 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 2483 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 165 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 869 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 479 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 1357 | 0.080 |
Why?
|
| Health Status | 1 | 2012 | 448 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 2679 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2015 | 2091 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2015 | 811 | 0.060 |
Why?
|
| Child | 3 | 2023 | 4598 | 0.060 |
Why?
|
| California | 1 | 2026 | 173 | 0.060 |
Why?
|
| Saliva | 1 | 2024 | 99 | 0.050 |
Why?
|
| Crithidia | 1 | 2023 | 2 | 0.050 |
Why?
|
| Focus Groups | 1 | 2024 | 318 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2024 | 229 | 0.050 |
Why?
|
| Creatinine | 1 | 2022 | 135 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 324 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2022 | 86 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 125 | 0.050 |
Why?
|
| Sexism | 1 | 2022 | 33 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 3299 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 359 | 0.040 |
Why?
|
| Genotype | 1 | 2022 | 670 | 0.040 |
Why?
|
| Self Report | 1 | 2023 | 390 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 146 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 768 | 0.040 |
Why?
|
| Multimorbidity | 1 | 2020 | 50 | 0.040 |
Why?
|
| Memory | 1 | 2020 | 123 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 259 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 251 | 0.040 |
Why?
|
| Longevity | 1 | 2019 | 117 | 0.040 |
Why?
|
| Massachusetts | 1 | 2024 | 2137 | 0.030 |
Why?
|
| Pregnancy | 1 | 2024 | 2363 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 1656 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2026 | 2238 | 0.030 |
Why?
|
| Adolescent | 2 | 2019 | 6290 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1580 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1434 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 376 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 66 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 292 | 0.030 |
Why?
|
| Naproxen | 1 | 2013 | 6 | 0.030 |
Why?
|
| Celecoxib | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2013 | 22 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 148 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 375 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2013 | 88 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2013 | 136 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 308 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1104 | 0.020 |
Why?
|
| Mental Health | 1 | 2014 | 360 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 1268 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 21309 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 6811 | 0.010 |
Why?
|